Biomarkers

Individualization of medicine calls for biomarkers. Our research cooperations have proven that Small Molecules (and peptides) can be very effective indicators.

Several biomarkers showed nearly 100 % specificity and 100 % sensitivity. This work resulted also in 4 patents all sold to collaborators/inventors.

European Patents:

EP 2 533 051 (Gaucher: Lysosomal Storage Disease)
EP 11 009 062.8 (NPC Niemann-Pick Disease)
EP 12 008 257.3 (MLD Metachromatic Leukodystrophy)
EP 21 722 497.1 (Predicting a Sepsis Condition)

Furthermore, we are dealing with the following diseases/disorders in biomarker research:

SEPSIS e.g. in Synovia
POMPE e.g. 7 different Biomarkers identified
FABRY e.g. lyso-Gb3
PFIC e.g. 27 different Biomarkers for 4 types of PFIC identified
WILSON e.g. 3 different Biomarkers identified
GLYCOGEN STORAGE DISEASES e.g. 3 different Biomarkers identified

Please click on picture to enlarge it